In order to further study the mechanism of the cancer-promoting effect of GBP1, we first conducted a alternative splicing analysis of GBP1 overexpression and suppressed expression, involving a total of 134 AS-related genes, and found that CD44 had A3SS alternative splicing events at the same base site in GBP1 overexpression and silencing. This evidence concerns the gene CD44 and cancer.